We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · September 26, 2019

Risk Categorization Using New ACC/AHA Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment

Circulation

 

Additional Info

Circulation
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
Circulation 2019 Sep 02;[EPub Ahead of Print], MT Roe, QH Li, DL Bhatt, VA Bittner, R Diaz, SG Goodman, RA Harrington, JW Jukema, P Lopez-Jaramillo, RD Lopes, MJ Louie, PM Moriarty, M Szarek, R Vogel, HD White, AM Zeiher, MT Baccara-Dinet, PG Steg, GG Schwartz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading